Simulations Plus 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Shawn O'Connor

최고 경영자

US$1.9m

총 보상

CEO 급여 비율	25.1%
CEO 임기	6.4yrs
CEO 소유권	n/a
경영진 평균 재임 기간	3.9yrs
이사회 평균 재임 기간	3.7yrs

최근 관리 업데이트

Recent updates

Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI

Feb 01

We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit

Jan 12

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Nov 06

Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Sep 06

Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Jun 28

Some Investors May Be Worried About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Feb 10

With EPS Growth And More, Simulations Plus (NASDAQ:SLP) Makes An Interesting Case

Nov 23

A Look At The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Oct 21

Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Sep 19

CEO 보상 분석

Shawn O'Connor 의 보수는 Simulations Plus 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Aug 31 2024	n/a	n/a	US$10m
May 31 2024	n/a	n/a	US$10m
Feb 29 2024	n/a	n/a	US$11m
Nov 30 2023	n/a	n/a	US$11m
Aug 31 2023	US$2m	US$487k	US$10m
May 31 2023	n/a	n/a	US$10m
Feb 28 2023	n/a	n/a	US$10m
Nov 30 2022	n/a	n/a	US$11m
Aug 31 2022	US$1m	US$450k	US$12m
May 31 2022	n/a	n/a	US$12m
Feb 28 2022	n/a	n/a	US$12m
Nov 30 2021	n/a	n/a	US$10m
Aug 31 2021	US$1m	US$444k	US$10m
May 31 2021	n/a	n/a	US$12m
Feb 28 2021	n/a	n/a	US$11m
Nov 30 2020	n/a	n/a	US$10m
Aug 31 2020	US$739k	US$350k	US$9m
May 31 2020	n/a	n/a	US$9m
Feb 29 2020	n/a	n/a	US$9m
Nov 30 2019	n/a	n/a	US$9m
Aug 31 2019	US$425k	US$325k	US$9m
May 31 2019	n/a	n/a	US$8m
Feb 28 2019	n/a	n/a	US$7m
Nov 30 2018	n/a	n/a	US$9m
Aug 31 2018	US$618k	US$54k	US$9m

보상 대 시장: Shawn 의 총 보상 ($USD 1.94M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 3.17M ).

보상과 수익: Shawn 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.

CEO

Shawn O'Connor (64 yo)

6.4yrs

테뉴어

US$1,942,004

보상

Mr. Shawn M. O'Connor has been Chief Executive Officer of Simulations Plus, Inc. since June 26, 2018. Mr. Shawn M. O'Connor joined Simulations Plus, Inc. in June 2018. Mr. O'Connor served as Chief Executiv...

리더십 팀

이름	위치	테뉴어	보상	소유권
Walter Woltosz	Co-Founder & Chairman	28.3yrs	US$199.99k	17.25% $ 108.4m
Shawn O'Connor	Chief Executive Officer	6.4yrs	US$1.94m	데이터 없음
William Frederick	COO, CFO & Secretary	3.9yrs	US$880.90k	0.010% $ 65.7k
John DiBella	President of PBPK & Cheminformatics Solutions	1.4yrs	US$728.14k	0.40% $ 2.5m
Jill Fiedler-Kelly	President of Clinical Pharmacology & Pharmacometrics Services	5.1yrs	US$722.10k	0.34% $ 2.2m
Jennifer Presnell	Accounting Manager	no data	데이터 없음	데이터 없음
Viera Lukacova	Chief Science Officer	4.2yrs	데이터 없음	데이터 없음
Bud Nelson	VP of Corporate Counsel & Personal Data Protection Officer	no data	데이터 없음	데이터 없음
Tanya Marvin	Marketing Manager	less than a year	데이터 없음	데이터 없음
Lindsay Luke	Executive Director of Human Resources	2.8yrs	데이터 없음	데이터 없음
Scott Siler	Chief Science Officer - Quantitative Systems Pharmacology	no data	데이터 없음	데이터 없음
Jonathan Chauvin	President of Clinical Pharmacology & Pharmacometrics Solutions	no data	데이터 없음	데이터 없음

3.9yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 관리: SLP 의 관리팀은 경험 ( 3.9 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Walter Woltosz	Co-Founder & Chairman	28.3yrs	US$199.99k	17.25% $ 108.4m
Daniel Weiner	lead Independent Director	7.5yrs	US$199.99k	0.040% $ 250.1k
Lisa LaVange	Independent Director	5.5yrs	US$189.99k	0.039% $ 244.3k
Ravindra Mehta	Member of Scientific Advisory Board	3.7yrs	데이터 없음	데이터 없음
Paul Watkins	Chairman of Scientific Advisory Board	3.7yrs	데이터 없음	데이터 없음
John Paglia	Independent Director	9.9yrs	US$199.99k	0.026% $ 165.3k
Frank Sistare	Member of Scientific Advisory Board	3.7yrs	데이터 없음	데이터 없음
Lauren Aleksunes	Member of Scientific Advisory Board	3.7yrs	데이터 없음	데이터 없음
K. Hallow	Member of Scientific Advisory Board	3.7yrs	데이터 없음	데이터 없음
Sharlene Evans	Independent Director	2.9yrs	US$187.49k	0.039% $ 246.2k

3.7yrs

평균 재임 기간

70yo

평균 연령

경험이 풍부한 이사회: SLP 의 이사회는 경험(평균 재직 기간 3.7 년)으로 간주됩니다.

Simulations Plus 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Simulations Plus, Inc. Announces Executive Changes, Effective August 30, 2024

lead Independent Director notifies of intention to sell stock

President of PBPK notifies of intention to sell stock

Simulations Plus, Inc., Annual General Meeting, Feb 08, 2024

Co-Founder & Chairman notifies of intention to sell stock

President exercised options to buy US$1.5m worth of stock.

Recent updates

Simulations Plus, Inc. and University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

We Think Simulations Plus' (NASDAQ:SLP) Healthy Earnings Might Be Conservative

Investor sentiment deteriorates as stock falls 16%

Price target decreased by 7.5% to US$52.75

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Simulations Plus, Inc. Provides Earnings Guidance for Fiscal Year 2025

Simulations Plus, Inc. to Report Q4, 2024 Results on Oct 23, 2024

Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings

Simulations Plus, Inc. Announces Executive Changes, Effective August 30, 2024

Simulations Plus: Declining Margins Are A Problem

Now 21% undervalued after recent price drop

Simulations Plus, Inc. Releases the latest version of its quantitative systems toxicology (QST) platform, DILIsym version X

Upcoming dividend of US$0.06 per share

Simulations Plus: Steady Growth, But What About The Margins?

Consensus EPS estimates fall by 14%

Third quarter dividend of US$0.06 announced

Third quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Simulations Plus, Inc. Updates Earnings Guidance for the Fiscal 2024

Now 12% overvalued after recent price rise

Now 21% overvalued after recent price rise

Simulations Plus, Inc. to Report Q3, 2024 Results on Jul 02, 2024

Consensus EPS estimates fall by 17%, revenue upgraded

Price target increased by 12% to US$60.33

Simulations Plus, Inc. (NasdaqGS:SLP) acquired Pro-ficiency, LLC from NovaQuest Capital Management, L.L.C., QHP Capital, L.P. and Pro-ficiency’s minority shareholders for approximately $100 million.

Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software

Simulations Plus: Reliance On Consulting And Acquisitions Creates Doubts

lead Independent Director notifies of intention to sell stock

Upcoming dividend of US$0.06 per share

Second quarter dividend of US$0.06 announced

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 43% overvalued after recent price rise

Simulations Plus, Inc. Declares a Cash Dividend, Payable on May 6, 2024

Why We're Not Concerned About Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price

Simulations Plus, Inc. to Report Q2, 2024 Results on Apr 03, 2024

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Now 22% overvalued after recent price rise

Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI

Simulations Plus, Inc. Releases GastroPlus Version 9.9

Upcoming dividend of US$0.06 per share at 0.6% yield

We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

President of PBPK notifies of intention to sell stock

Simulations Plus, Inc., Annual General Meeting, Feb 08, 2024

Simulations Plus, Inc. to Report Q1, 2024 Results on Jan 03, 2024

Simulations Plus, Inc. Reiterates Earnings Guidance for the Fiscal Year 2024

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Price target decreased by 9.1% to US$53.33

Simulations Plus, Inc. Declares Cash Dividend , Payable on November 6, 2023

Simulations Plus, Inc. to Report Q4, 2023 Results on Oct 25, 2023

Simulations Plus Receives New FDA Grant Award

Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Upcoming dividend of US$0.06 per share at 0.5% yield

Simulations Plus, Inc. Releases ADMET Predictor® 11

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Simulations Plus, Inc. Declares Cash Dividend , Payable on August 7, 2023

Co-Founder & Chairman notifies of intention to sell stock

Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Simulations Plus, Inc. to Report Q3, 2023 Results on Jul 06, 2023

Simulations Plus, Inc. (NasdaqGS:SLP) acquired Immunetrics, Inc. from LaunchCyte LLC for $23.5 million.

Price target decreased by 12% to US$55.00

Upcoming dividend of US$0.06 per share at 0.5% yield

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

President exercised options to buy US$1.5m worth of stock.

President notifies of intention to sell stock

Simulations Plus Releases Redesigned NAFLDsym QSP Software Tool

Some Investors May Be Worried About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Upcoming dividend of US$0.06 per share

Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure

First quarter 2023 earnings: EPS and revenues miss analyst expectations